申请人:Boulos & Cooper Pharmaceuticals Pty Ltd
                            
                            
                                公开号:US20190328691A1
                            
                            
                                公开(公告)日:2019-10-31
                            
                            The present invention provides a composition comprising a combination of: (i) at least one aryl antibiotic comprising a compound having a structure selected from Group I, or a pharmaceutically acceptable salt thereof; and (ii) at least one antibiotic selected from the list comprising a penicillin or a derivative thereof, a cepham or a derivative thereof, vancomycin, linezolid, daptomycin and mupirocin.